iPLEDGE
Jump to navigation
Jump to search
Introduction
A mandatory distribution program in the United States for isotretinoin, intended to prevent use during pregnancy due to the high risk of birth defects. As of March 1, 2006, patients & their doctors & pharmacists are required by the FDA to register & use the iPLEDGE website[2] in order to receive isotretinoin.
References
- ↑ WikiPedia: iPLEDGE http://en.wikipedia.org/wiki/IPLEDGE
- ↑ 2.0 2.1 iPLEDGE http://www.ipledgeprogram.com